INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2013
|
Total net assets |
£159.1m |
|
NAV per share |
288.4p |
|
Share price |
254.0p |
|
Total value of unquoted investments |
£25.5m |
|
Total number of portfolio companies |
68 |
|
Cash |
1% NAV |
|
Cash committed and reserved to unquoted investments |
(5.7%) NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen Gilead Celgene |
6.9 6.7 5.9 |
|
Alexion |
5.3 |
|
Biogen |
5.2 |
|
Regeneron |
5.0 |
|
Onyx |
4.3 |
|
Aptiv |
3.7 |
|
Vertex |
3.2 |
|
Incyte |
3.0 |
|
|
----------- |
|
Total |
49.2 |
|
Geographical Allocation |
% |
|
United States & Canada |
91 |
|
Europe |
8 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
82 |
|
Unquoted |
17 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 JULY 2013